vimseltinib
deciphera,deciphera
['vimseltinib', 'deciphera']
#company_news_ deciphera pharmaceuticals, inc. presents updated phase 1/2 data for vimseltinib in tgct at the european society for medical oncology (esmo) congress 2022 
With over a thousand ETFs to choose from picking the right one can be complicated - Trading Strategies https://t.co/eUyJZgygom